You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vilazodone Hydrochloride

Showing 51 - 75 of 1,793
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Breast Cancer Trial in Shijiazhuang (Doxorubicin HCl liposome injection)

Completed
  • Advanced Breast Cancer
  • Doxorubicin hydrochloride liposome injection
  • Shijiazhuang, China
    The Fourth Hospital of Hebei Medical University
Oct 18, 2023

MDD (MDD) Trial (Ammoxetine, Placebo)

Not yet recruiting
  • Major Depressive Disorder (MDD)
  • (no location specified)
Feb 28, 2023

Gastric Cancer Trial in Xi'an (Penpulimab combined with Anlotinib Hydrochloride Capsules and chemo;Cadonilimab combined with

Not yet recruiting
  • Gastric Cancer
  • Penpulimab combined with Anlotinib Hydrochloride Capsules and chemotherapy;Cadonilimab combined with Anlotinib Hydrochloride Capsules and chemotherapy
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of Air Force Military Medical Univ
Mar 23, 2023

Generalized Anxiety Disorder Trial in Beijing (Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg,

Not yet recruiting
  • Generalized Anxiety Disorder
  • Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg
  • +2 more
  • Beijing, China
    Peking University Sixth Hospital
Aug 1, 2023

Metastatic Cancer, Unspecified Adult Solid Tumor Trial in Los Angeles (PARP inhibitor BMN-673, temozolomide, irinotecan HCl)

Completed
  • Metastatic Cancer
  • Unspecified Adult Solid Tumor
  • PARP inhibitor BMN-673
  • +4 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Sep 22, 2022

Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Mitoxantrone hydrochloride liposome injection
  • +3 more
  • (no location specified)
May 29, 2023

Erectile Dysfunction Trial in Peking (Tunodafil Hydrochloride Tablets, Placebo, Alcohol)

Completed
  • Erectile Dysfunction
  • Tunodafil Hydrochloride Tablets
  • +2 more
  • Peking, China
    Peking University People's Hospital
Jul 28, 2023

Colon Adenocarcinoma, ERBB2 Gene Amplification, Rectal Adenocarcinoma Trial in Puerto Rico, United States (biological, drug,

Active, not recruiting
  • Colon Adenocarcinoma
  • +18 more
  • Cetuximab
  • +5 more
  • Anchorage, Alaska
  • +797 more
Jan 9, 2023

To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced

Not yet recruiting
  • To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer
  • Hydrochloride anlotinib
  • +2 more
  • (no location specified)
Mar 6, 2023

Advanced Malignant Solid Tumor, C-Reactive Protein Measurement, Cancer Fatigue Trial in Houston (drug, behavioral, other)

Active, not recruiting
Has Results
  • Advanced Malignant Solid Neoplasm
  • +5 more
  • Anamorelin Hydrochloride
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Dravet Syndrome Trial in Memphis (fenfluramine)

Recruiting
  • Dravet Syndrome
  • Memphis, Tennessee
    Ep0213 105
Nov 9, 2023

Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Duarte, California
  • +15 more
Aug 11, 2022

Advanced Hepatocellular Carcinoma Trial in China (Penpulimab injection, TQB2618 injection, Anlotinib Hydrochloride Capsules)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Penpulimab injection
  • +2 more
  • Wuwei, Gansu, China
  • +7 more
Jul 27, 2023

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Active, not recruiting
  • Recurrent Anaplastic Astrocytoma
  • +6 more
  • Carboxylesterase-expressing Allogeneic Neural Stem Cells
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester

Active, not recruiting
Has Results
  • Cholangiocarcinoma
  • +6 more
  • Laboratory Biomarker Analysis
  • Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
  • Scottsdale, Arizona
  • +1 more
Jan 4, 2023

Seasonal Allergic Rhinitis Trial in Toronto (Mometasone + Azelastine, Mometasone Furoate, Azelastine Hydrochloride)

Not yet recruiting
  • Seasonal Allergic Rhinitis
  • Mometasone + Azelastine
  • +2 more
  • Toronto, Ontario, Canada
    Sandoz Investigational Site
May 24, 2023

CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in

Active, not recruiting
Has Results
  • Central Nervous System Embryonal Tumor With Rhabdoid Features
  • +14 more
  • Birmingham, Alabama
  • +23 more
Oct 7, 2022

Pain, Postoperative, Opioid Use, Perioperative Complication Trial (bupivacaine liposome injectable suspension, Bupivacaine

Not yet recruiting
  • Pain, Postoperative
  • +3 more
  • bupivacaine liposome injectable suspension
  • Bupivacaine Hydrochloride
  • (no location specified)
Oct 4, 2023

Metastatic Fallopian Tube Carcinoma, Metastatic Ovarian Carcinoma, Metastatic Primary Peritoneal Carcinoma Trial in United

Active, not recruiting
  • Metastatic Fallopian Tube Carcinoma
  • +11 more
  • Phoenix, Arizona
  • +13 more
Dec 2, 2022

Classical Hodgkin Lymphoma Trial in Seattle (drug, other, biological)

Recruiting
  • Classical Hodgkin Lymphoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma Trial in Worldwide (Dinutuximab, Eflornithine

Recruiting
  • High Risk Neuroblastoma
  • +2 more
  • Dinutuximab
  • +4 more
  • Birmingham, Alabama
  • +141 more
Dec 28, 2022

Healthy Trial in Taipei (Phencynonate HCl)

Completed
  • Healthy
  • Phencynonate hydrochloride
  • Taipei, Taiwan
    General Clinical Research Center for New Drug Trial, Tri-Service
Jun 13, 2022

Pharmacokinetics Trial in Burnaby (Berberine LipoMicel, Regular Berberine soft-gels, Regular Berberine hard-gels)

Completed
  • Pharmacokinetics
  • Berberine LipoMicel
  • +3 more
  • Burnaby, British Columbia, Canada
    ISURA
Dec 30, 2022

Atopic Dermatitis Trial in Beijing (Jaktinib Hydrochloride Tablet)

Recruiting
  • Atopic Dermatitis
  • Jaktinib Hydrochloride Tablet
  • Beijing, Beijing, China
    11 Xizhimen South Street
Jan 6, 2023

BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Tumor Trial in Houston (biological, drug, other)

Active, not recruiting
  • BRAF NP_004324.2:p.V600X
  • +6 more
  • Cetuximab
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022